$OMER Did everyone see this paper about the abstract from ASH2019 ?also a little covid19 teaser in thw end. "MASP2 levels are elevated in thrombotic microangiopathies: Association with microvascular endothelial cell injury and suppression by anti‐MASP2 antibody narsoplimab" onlinelibrary.wiley.com/doi...
  • 11
@cdm85 @almostfamous Don’t fully understand science, but OMER patents on MASP 2 with multiple Narso disease application w/resulting B $ Rev potential is why I’m here! When considering rest of Omers DEEP DEEP Pipeline, the 700MM MC makes absolutely no sense to me. Continuing long & strong 💪 as fuse gets shorter and shorter! Thx for DD....
  • 7
@AgentMulder @almostfamous yes sick undervalued on global rights to selective iCABs which clearly beats downstream complement blockers which is inferior and dangerous. If you want to slay the dragon go for the head not tail 🐲 ⚔
  • 8